financetom
Business
financetom
/
Business
/
Transcat CEO Lee Rudow to Retire in March 2026
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Transcat CEO Lee Rudow to Retire in March 2026
Aug 25, 2025 1:50 PM

04:18 PM EDT, 08/25/2025 (MT Newswires) -- Transcat ( TRNS ) said late Monday that Chief Executive Officer Lee Rudow plans to retire in March 2026.

After a new CEO is named, Rudow will move to an advisory role, the company said.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Vital Energy Insider Sold Shares Worth $5,469,188, According to a Recent SEC Filing
Vital Energy Insider Sold Shares Worth $5,469,188, According to a Recent SEC Filing
Jul 11, 2025
04:46 PM EDT, 07/11/2025 (MT Newswires) -- Richard D Campbell, 10% Owner, on July 09, 2025, sold 300,000 shares in Vital Energy ( VTLE ) for $5,469,188. Following the Form 4 filing with the SEC, Campbell has control over a total of 7,568,933 common shares of the company, with 7,568,933 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1528129/000177446325000004/xslF345X05/primary_doc.xml ...
Salesforce Insider Sold Shares Worth $598,854, According to a Recent SEC Filing
Salesforce Insider Sold Shares Worth $598,854, According to a Recent SEC Filing
Jul 11, 2025
04:48 PM EDT, 07/11/2025 (MT Newswires) -- Marc Benioff, Director, Chair and CEO, on July 10, 2025, sold 2,250 shares in Salesforce ( CRM ) for $598,854. Following the Form 4 filing with the SEC, Benioff has control over a total of 22,062,566 common shares of the company, with 11,955,566 shares held directly and 10,107,000 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1108524/000112760225019093/xslF345X05/form4.xml...
US FDA declines to approve Ultragenyx's gene therapy for rare inherited disorder
US FDA declines to approve Ultragenyx's gene therapy for rare inherited disorder
Jul 11, 2025
July 11 (Reuters) - The U.S. Food and Drug Administration has declined to approve Ultragenyx Pharmaceutical's ( RARE ) experimental gene therapy to treat a rare inherited disorder, citing manufacturing concerns, the company said on Friday. The therapy, UX111, was developed to treat Sanfilippo syndrome type A - a rare, inherited disorder that begin in early childhood causing severe brain...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved